Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HOTBreast: Hormone Therapy Initiation Immediately After Diagnosis of Breast Cancer
NCT03111615Phase 4Unknown
- Sponsor
- Centro Hospitalar de Lisboa Ocidental
- Start
- May 2018
- Primary completion
- May 2019
- Countries
- 1
01
Overview
Phase 4, randomised trial in breast cancer (4 arms), sponsored by Centro Hospitalar de Lisboa Ocidental. Primary endpoint: Tumor Biology at 6 weeks. Status: unknown.
02
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03111615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03111615.